Soft-tissue plasmacytomas complicates the course of multiple myeloma (clinical cases)

by L P Mendeleeva, O S Pokrovskaya, M V Nareyko, D S Dubnyak, M V Firsova, I E Kostina, G A Yacik, T V Abramova, A M Kovrigina, V N Dvirnik
Published 2015-12-01

CHARACTERISTICS OF DIAGNOSTIC APPROACH TO ERYTHROCYTOSIS OF DIFFERENT GENESIS

by M A Sokolova, N D Khoroshko, M G Dmitrieva, V S Zhuravlev, N Sh Sagdieva, M O Egorova, N S Moiseeva, M V Nareyko, A G Gemdjan, I D Sahibov
Published 2012-04-01

Multiple myeloma: Maintenance therapy after autologous hematopoietic stem cell transplantation, depending on minimal residual disease

by M V Solovyev, L P Mendeleeva, O S Pokrovskaya, M V Nareyko, M V Firsova, I V Galtseva, Yu O Davydova, N M Kapranov, L A Kuzmina, E G Gemdzhian, V G Savchenko
Published 2017-07-01

Extranodal NK/T-cell lymphoma: a review of literature and case report

by N. G. Chernova, M. V. Nareyko, M. N. Sinitsyna, Yu. V. Sidorova, G. A. Yatsy, A. M. Kovrigina, E. E. Zvonkov, V. N. Dvirnyk, L. A. Kuz’mina, E. N. Parovichnikova, V. G. Savchenko
Published 2016-10-01

Prognostic value of 1q21 amplification in multiple myeloma

by T V Abramova, T N Obukhova, L P Mendeleeva, O S Pokrovskaya, E O Gribanova, V V Ryzhko, L A Grebenyuk, M V Nareyko, M V Solovyev, O M Votyakova, S M Kulikov, M A Rusinov, V G Savchenko
Published 2017-07-01